We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » More Evidence Needed to Cover Cyberonics' VNS Device
More Evidence Needed to Cover Cyberonics' VNS Device
April 28, 2006
Health insurance giant Aetna will not provide coverage for Houston-based Cyberonics’ vagus nerve stimulation (VNS) therapy for treatment-resistant depression (TRD), Aetna said April 21.